CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-04-02 10:18 Tx date 2024-01-31	$APS Aptose Biosciences Inc.	Hanmi Pharmaceutical Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 11 - Acquisition or disposition carried out privately	+2,339,181 vol	2,339,181
Filed 2024-04-02 10:16 Tx date 2023-09-05	$APS Aptose Biosciences Inc.	Hanmi Pharmaceutical Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Warrants 00 - Opening Balance-Initial SEDI Report
Filed 2024-04-02 10:11 Tx date 2024-01-31	$APS Aptose Biosciences Inc.	Hanmi Pharmaceutical Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$3,999,999 +2,105,263 vol $1.90 each	2,989,415
Filed 2024-02-08 10:06 Tx date 2024-02-05	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,333 vol	40,227
Filed 2024-02-08 10:04 Tx date 2024-02-05	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+35,000 vol	177,864
Filed 2024-02-08 10:02 Tx date 2024-02-05	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+55,000 vol	134,999
Filed 2024-02-08 10:01 Tx date 2024-02-05	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,333 vol	40,649
Filed 2024-02-08 09:57 Tx date 2024-02-05	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,333 vol	37,995
Filed 2024-02-08 09:55 Tx date 2024-02-05	$APS Aptose Biosciences Inc.	Seizinger, Bernd Robert 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,333 vol	13,332
Filed 2024-02-08 09:53 Tx date 2024-02-05	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,333 vol	37,328
Filed 2024-02-08 09:52 Tx date 2024-02-05	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+70,000 vol	477,658
Filed 2024-02-08 09:49 Tx date 2024-02-05	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+11,000 vol	64,333
Filed 2023-09-25 17:16 Tx date 2023-09-22	$APS Aptose Biosciences Inc.	Seizinger, Bernd Robert 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$21,895 +7,000 vol $3.13 each	17,000
Filed 2023-09-25 17:15 Tx date 2023-09-22	$APS Aptose Biosciences Inc.	Seizinger, Bernd Robert 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$31,400 +10,000 vol $3.14 each	10,000
Filed 2023-09-07 11:43 Tx date 2023-09-06	$APS Aptose Biosciences Inc.	Hanmi Pharmaceutical Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	$2,999,999 +668,449 vol $4.49 each	884,152
Filed 2023-09-07 11:42 Tx date 2023-09-05	$APS Aptose Biosciences Inc.	Hanmi Pharmaceutical Co., Ltd. 3 - 10% Security Holder of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		215,703
Filed 2023-08-18 13:27 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-476,005 vol	33,995
Filed 2023-08-18 13:26 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-14,000 vol	1,000
Filed 2023-08-18 09:41 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Holder: Fletcher Payne 2019 Trust (Indirect Ownership)	Common Shares 37 - Stock split or consolidation	-9,334 vol	666
Filed 2023-08-18 09:39 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-1,120,001 vol	79,999
Filed 2023-08-18 09:38 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-93,334 vol	6,666
Filed 2023-08-17 20:53 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-521,189 vol	36,894
Filed 2023-08-17 20:52 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-6,067 vol	433
Filed 2023-08-17 20:49 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Seizinger, Bernd Robert 4 - Director of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-140,001 vol	9,999
Filed 2023-08-17 20:43 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-485,338 vol	34,662
Filed 2023-08-17 20:42 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-471,334 vol	33,666
Filed 2023-08-17 20:36 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-746,667 vol	53,333
Filed 2023-08-17 20:35 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-93,800 vol	6,700
Filed 2023-08-17 20:31 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-527,935 vol	37,316
Filed 2023-08-17 20:30 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-20,227 vol	1,444
Filed 2023-08-17 20:26 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-2,000,136 vol	142,864
Filed 2023-08-17 20:25 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-102,667 vol	7,333
Filed 2023-08-17 20:21 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Ashe, Carol Gail 4 - Director of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-354,670 vol	25,330
Filed 2023-08-11 11:02 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-5,707,305 vol	407,658
Filed 2023-08-11 10:58 Tx date 2023-05-24	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-479,036 vol	34,216
Filed 2023-01-24 15:54 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	510,000
Filed 2023-01-24 15:53 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	558,083
Filed 2023-01-24 15:51 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	565,251
Filed 2023-01-24 15:49 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Ashe, Carol Gail 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	380,000
Filed 2023-01-24 15:47 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Seizinger, Bernd Robert 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	150,000
Filed 2023-01-24 15:45 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	520,000
Filed 2023-01-24 15:44 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+100,000 vol	100,000
Filed 2023-01-24 15:43 Tx date 2022-06-27	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-24 15:43 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-100,000 vol	0
Filed 2023-01-24 15:42 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+100,000 vol	100,000
Filed 2023-01-24 15:42 Tx date 2022-06-27	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-24 15:42 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+200,000 vol	1,200,000
Filed 2023-01-24 15:40 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+100,000 vol	100,500
Filed 2023-01-24 15:39 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-100,000 vol	0
Filed 2023-01-24 15:38 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+100,000 vol	100,000
Filed 2023-01-24 15:38 Tx date 2022-04-06	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-24 15:38 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+200,000 vol	800,000
Filed 2023-01-24 15:36 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+100,000 vol	110,000
Filed 2023-01-24 15:35 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-100,000 vol	0
Filed 2023-01-24 15:34 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+100,000 vol	100,000
Filed 2023-01-24 15:34 Tx date 2020-01-01	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2023-01-24 15:33 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+200,000 vol	2,143,000
Filed 2023-01-24 15:30 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+150,000 vol	513,252
Filed 2023-01-24 15:29 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-150,000 vol	0
Filed 2023-01-24 15:28 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+150,000 vol	150,000
Filed 2023-01-24 15:28 Tx date 2023-01-19	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+400,000 vol	6,114,963
Filed 2022-09-22 10:01 Tx date 2022-09-19	$APS Aptose Biosciences Inc.	Payne, Charles Fletcher 5 - Senior Officer of Issuer Holder: Fletcher Payne 2019 Trust (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$6,775 +10,000 vol $0.68 each	10,000
Filed 2022-09-22 09:53 Tx date 2022-09-19	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,939 +4,300 vol $0.68 each	363,252
Filed 2022-09-22 09:52 Tx date 2022-09-19	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,895 +5,700 vol $0.68 each	358,952
Filed 2022-09-16 18:04 Tx date 2022-09-14	$APS Aptose Biosciences Inc.	Seizinger, Bernd Robert 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	50,000
Filed 2022-09-16 18:02 Tx date 2022-09-13	$APS Aptose Biosciences Inc.	Seizinger, Bernd Robert 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-09-16 18:02 Tx date 2022-09-13	$APS Aptose Biosciences Inc.	Seizinger, Bernd Robert 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-07-08 14:52 Tx date 2022-07-06	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+600,000 vol	5,714,963
Filed 2022-06-28 16:27 Tx date 2022-06-27	$APS Aptose Biosciences Inc.	Charles Fletcher, Payne 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+1,000,000 vol	1,000,000
Filed 2022-06-28 16:26 Tx date 2022-06-27	$APS Aptose Biosciences Inc.	Charles Fletcher, Payne 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-06-07 15:18 Tx date 2022-06-06	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,709 +1,762 vol $0.97 each	353,252
Filed 2022-06-07 15:17 Tx date 2022-06-06	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,940 +4,062 vol $0.97 each	351,490
Filed 2022-06-07 15:16 Tx date 2022-06-06	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,351 +1,400 vol $0.97 each	347,428
Filed 2022-06-07 15:16 Tx date 2022-06-06	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,679 +2,776 vol $0.97 each	346,028
Filed 2022-04-15 13:45 Tx date 2022-04-13	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+600,000 vol	600,000
Filed 2022-04-15 13:43 Tx date 2022-04-06	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-04-13 19:05 Tx date 2022-04-06	$APS Aptose Biosciences Inc.	Ledru, Philippe 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		500
Filed 2022-01-20 18:52 Tx date 2022-01-18	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+700,000 vol	5,114,963
Filed 2022-01-20 18:49 Tx date 2022-01-18	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+600,000 vol	2,063,000
Filed 2022-01-20 18:46 Tx date 2022-01-18	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+600,000 vol	1,943,000
Filed 2022-01-20 18:44 Tx date 2022-01-18	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	458,083
Filed 2022-01-20 18:42 Tx date 2022-01-18	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	465,251
Filed 2022-01-20 18:40 Tx date 2022-01-18	$APS Aptose Biosciences Inc.	Loewy, Caroline Marie 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	280,000
Filed 2022-01-20 18:37 Tx date 2022-01-18	$APS Aptose Biosciences Inc.	Ashe, Carol Gail 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	280,000
Filed 2022-01-20 18:34 Tx date 2022-01-18	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	410,000
Filed 2022-01-20 18:30 Tx date 2022-01-18	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	420,000
Filed 2021-12-28 18:20 Tx date 2021-12-20	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$14,490 +10,000 vol $1.45 each
Filed 2021-12-21 12:08 Tx date 2021-12-20	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$14,490 +10,000 vol $1.45 each
Filed 2021-12-21 12:08 Tx date 2021-12-20	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$14,490 +10,000 vol $1.45 each	31,671
Filed 2021-12-20 19:40 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$26,600 +19,000 vol $1.40 each	505,000
Filed 2021-12-20 19:39 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,255 +900 vol $1.40 each	486,000
Filed 2021-12-20 19:39 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$139.40 +100 vol $1.39 each	485,100
Filed 2021-12-20 19:38 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$23,403 +16,837 vol $1.39 each	485,000
Filed 2021-12-20 19:38 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,464 +3,960 vol $1.38 each	468,163
Filed 2021-12-20 19:37 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$137.50 +100 vol $1.38 each	464,203
Filed 2021-12-20 19:37 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$79,734 +58,200 vol $1.37 each	464,103
Filed 2021-12-20 19:36 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,232 +903 vol $1.36 each	405,903
Filed 2021-12-17 17:57 Tx date 2021-12-15	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$117,600 +100,000 vol $1.18 each	405,000
Filed 2021-12-17 17:57 Tx date 2021-12-15	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$35,700 +30,000 vol $1.19 each	305,000
Filed 2021-12-17 17:56 Tx date 2021-12-15	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$23,960 +20,000 vol $1.20 each	275,000
Filed 2021-12-17 17:56 Tx date 2021-12-15	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$139,080 +120,000 vol $1.16 each	255,000
Filed 2021-12-17 17:45 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,830 +2,520 vol $1.52 each	343,252
Filed 2021-12-17 17:44 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,794 +2,480 vol $1.53 each	340,732
Filed 2021-12-17 17:44 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$7,599 +5,000 vol $1.52 each	338,252
Filed 2021-12-17 17:43 Tx date 2021-12-16	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,774 +3,183 vol $1.50 each	333,252
Filed 2021-12-15 15:59 Tx date 2021-12-15	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,964 +1,754 vol $1.12 each	330,069
Filed 2021-12-15 15:59 Tx date 2021-12-15	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,549 +5,000 vol $1.11 each	328,315
Filed 2021-12-15 15:58 Tx date 2021-12-15	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,684 +3,246 vol $1.14 each	323,315
Filed 2021-12-15 15:58 Tx date 2021-12-15	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,641 +5,000 vol $1.13 each	320,069
Filed 2021-12-15 15:57 Tx date 2021-12-15	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,160 +2,822 vol $1.12 each	315,069
Filed 2021-11-29 16:06 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$325.32 +143 vol $2.27 each	312,247
Filed 2021-11-29 16:06 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,136 +500 vol $2.27 each	312,104
Filed 2021-11-29 16:05 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,147 +500 vol $2.29 each	311,604
Filed 2021-11-29 16:04 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,149 +500 vol $2.30 each	311,104
Filed 2021-11-29 16:03 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$924.00 +400 vol $2.31 each	310,604
Filed 2021-11-29 16:02 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,385 +600 vol $2.31 each	310,204
Filed 2021-11-29 16:01 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,319 +1,000 vol $2.32 each	309,604
Filed 2021-11-29 15:59 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,319 +1,000 vol $2.32 each	308,604
Filed 2021-11-29 15:59 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,637 +2,000 vol $2.32 each	307,604
Filed 2021-11-29 15:55 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,328 +1,000 vol $2.33 each	305,604
Filed 2021-11-29 15:52 Tx date 2021-11-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,325 +1,000 vol $2.33 each	304,604
Filed 2021-11-22 10:35 Tx date 2021-11-19	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$13,975 +5,417 vol $2.58 each	21,671
Filed 2021-11-22 10:34 Tx date 2021-11-19	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-5,417 vol	415,251
Filed 2021-11-22 10:30 Tx date 2021-11-19	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$25,600 +10,000 vol $2.56 each	10,000
Filed 2021-11-22 10:27 Tx date 2020-01-01	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-08-23 17:56 Tx date 2021-08-19	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+400,000 vol	1,343,000
Filed 2021-08-23 17:52 Tx date 2021-08-19	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+400,000 vol	1,463,000
Filed 2021-07-06 17:34 Tx date 2021-07-02	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,277 +1,000 vol $3.28 each	303,604
Filed 2021-07-06 17:33 Tx date 2021-07-02	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,285 +1,000 vol $3.29 each	302,604
Filed 2021-07-06 17:32 Tx date 2021-07-02	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,556 +1,081 vol $3.29 each	301,604
Filed 2021-07-06 17:31 Tx date 2021-07-02	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,590 +2,000 vol $3.29 each	300,523
Filed 2021-07-06 17:30 Tx date 2021-07-02	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,280 +1,000 vol $3.28 each	298,523
Filed 2021-06-23 17:24 Tx date 2021-06-22	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-38,419.20 -9,600 vol $4.00 each	15,000
Filed 2021-06-23 17:22 Tx date 2021-06-21	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-63,848.40 -15,400 vol $4.15 each	24,600
Filed 2021-01-06 20:12 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+343,000 vol	4,414,963
Filed 2021-01-06 20:02 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Ashe, Carol Gail 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	230,000
Filed 2021-01-06 20:00 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Loewy, Caroline Marie 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	230,000
Filed 2021-01-06 19:58 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	370,000
Filed 2021-01-06 19:56 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	420,668
Filed 2021-01-06 19:54 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	360,000
Filed 2021-01-06 19:52 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	408,083
Filed 2021-01-06 19:49 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+343,000 vol	943,000
Filed 2021-01-06 19:46 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+343,000 vol	1,063,000
Filed 2021-01-06 19:42 Tx date 2021-01-04	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+343,000 vol	2,805,501
Filed 2020-12-29 07:27 Tx date 2020-12-22	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-53,003 -10,000 vol $5.30 each	40,000
Filed 2020-12-29 07:27 Tx date 2020-12-22	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-51,745 -10,000 vol $5.17 each	50,000
Filed 2020-12-29 07:26 Tx date 2020-12-22	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$52,000 +20,000 vol $2.60 each	60,000
Filed 2020-12-29 07:25 Tx date 2020-12-22	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-20,000 vol	310,000
Filed 2020-07-10 19:37 Tx date 2020-07-10	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,021,790.55 -168,891 vol $6.05 each	297,523
Filed 2020-07-10 19:35 Tx date 2020-07-10	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+300,000 vol	466,414
Filed 2020-07-10 19:34 Tx date 2020-07-10	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-300,000 vol	0
Filed 2020-07-10 19:32 Tx date 2020-07-10	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-380,151.75 -62,835 vol $6.05 each	116,219
Filed 2020-07-10 19:30 Tx date 2020-07-10	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+120,000 vol	179,054
Filed 2020-07-10 19:29 Tx date 2020-07-10	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-120,000 vol	0
Filed 2020-07-10 19:26 Tx date 2020-07-10	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-766,341.40 -126,668 vol $6.05 each	232,846
Filed 2020-07-10 19:24 Tx date 2020-07-10	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+225,000 vol	359,514
Filed 2020-07-10 19:23 Tx date 2020-07-10	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-225,000 vol	0
Filed 2020-07-03 15:54 Tx date 2020-07-02	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-132,793.4508 -20,946 vol $6.34 each	59,054
Filed 2020-07-03 15:51 Tx date 2020-07-02	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+40,000 vol	80,000
Filed 2020-07-03 15:50 Tx date 2020-07-02	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-40,000 vol	120,000
Filed 2020-06-29 08:53 Tx date 2020-06-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-63,000 -7,000 vol $9.00 each	40,000
Filed 2020-06-29 08:53 Tx date 2020-06-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-46,100 -5,000 vol $9.22 each	47,000
Filed 2020-06-29 08:52 Tx date 2020-06-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-4,590 -500 vol $9.18 each	52,000
Filed 2020-06-29 08:51 Tx date 2020-06-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-33,929 -3,700 vol $9.17 each	52,500
Filed 2020-06-29 08:51 Tx date 2020-06-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-7,320 -800 vol $9.15 each	56,200
Filed 2020-06-29 08:50 Tx date 2020-06-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$24,640 +7,000 vol $3.52 each	57,000
Filed 2020-06-29 08:50 Tx date 2020-06-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$6,899 +5,000 vol $1.38 each	50,000
Filed 2020-06-29 08:49 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-95,500 -10,000 vol $9.55 each	45,000
Filed 2020-06-29 08:48 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-28,920 -3,000 vol $9.64 each	55,000
Filed 2020-06-29 08:47 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-48,450 -5,000 vol $9.69 each	58,000
Filed 2020-06-29 08:47 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$15,200 +10,000 vol $1.52 each	63,000
Filed 2020-06-29 08:46 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,125 +1,250 vol $5.70 each	53,000
Filed 2020-06-29 08:46 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$1,080 +500 vol $2.16 each	51,750
Filed 2020-06-29 08:45 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$3,225 +1,250 vol $2.58 each	51,250
Filed 2020-06-29 08:44 Tx date 2020-06-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-7,000 vol	330,000
Filed 2020-06-29 08:43 Tx date 2020-06-24	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-5,000 vol	337,000
Filed 2020-06-29 08:42 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-10,000 vol	342,000
Filed 2020-06-29 08:41 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-1,250 vol	352,000
Filed 2020-06-29 08:41 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-500 vol	353,250
Filed 2020-06-29 08:40 Tx date 2020-06-23	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-1,250 vol	353,750
Filed 2020-03-26 16:20 Tx date 2020-03-25	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$19,802 +3,400 vol $5.82 each	166,414
Filed 2020-03-14 14:04 Tx date 2020-03-10	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+120,000 vol	160,000
Filed 2020-03-14 14:02 Tx date 2020-03-10	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+225,000 vol	225,000
Filed 2020-03-14 14:00 Tx date 2020-03-10	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+300,000 vol	300,000
Filed 2020-03-14 13:57 Tx date 2020-03-11	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	320,000
Filed 2020-03-14 13:55 Tx date 2020-03-11	$APS Aptose Biosciences Inc.	Loewy, Caroline Marie 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	180,000
Filed 2020-03-14 13:53 Tx date 2020-03-11	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	370,668
Filed 2020-03-14 13:51 Tx date 2020-03-11	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	358,083
Filed 2020-03-14 13:48 Tx date 2020-03-11	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	355,000
Filed 2020-03-14 13:46 Tx date 2020-03-11	$APS Aptose Biosciences Inc.	Ashe, Carol Gail 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	180,000
Filed 2020-02-03 11:19 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+152,500 vol	305,000
Filed 2020-02-03 11:17 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+154,000 vol	308,083
Filed 2020-02-03 11:15 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Ashe, Carol Gail 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+65,000 vol	130,000
Filed 2020-02-03 11:13 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Loewy, Caroline Marie 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+65,000 vol	130,000
Filed 2020-02-03 11:09 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+135,000 vol	270,000
Filed 2020-02-03 11:07 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+160,334 vol	320,668
Filed 2020-02-03 11:05 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+200,000 vol	600,000
Filed 2020-02-03 11:03 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+400,000 vol	720,000
Filed 2020-02-03 11:00 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+1,200,000 vol	2,462,501
Filed 2020-02-03 10:56 Tx date 2020-01-31	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+2,000,000 vol	4,071,963
Filed 2020-01-03 17:11 Tx date 2020-01-01	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+400,000 vol	400,000
Filed 2020-01-03 17:06 Tx date 2020-01-01	$APS Aptose Biosciences Inc.	Bejar, Rafael 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-10-28 11:39 Tx date 2019-10-24	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$19,200 +10,000 vol $1.92 each	163,014
Filed 2019-09-06 10:40 Tx date 2019-09-03	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+40,000 vol	40,000
Filed 2019-09-06 10:39 Tx date 2019-06-03	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2019-09-06 10:37 Tx date 2019-09-03	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-40,000 vol	40,000
Filed 2019-06-07 10:03 Tx date 2019-06-05	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$13,815 +7,500 vol $1.84 each	134,514
Filed 2019-06-04 15:04 Tx date 2019-06-03	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+320,000 vol	320,000
Filed 2019-06-04 15:03 Tx date 2019-06-03	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-06-04 15:03 Tx date 2019-06-03	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+40,000 vol	80,000
Filed 2019-06-04 15:02 Tx date 2019-06-03	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+40,000 vol	40,000
Filed 2019-06-04 15:01 Tx date 2019-06-03	$APS Aptose Biosciences Inc.	Marango, Jotin 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2019-04-22 09:05 Tx date 2019-04-18	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$18,507 +10,000 vol $1.85 each	153,014
Filed 2019-03-20 Tx date 2019-03-19	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$32,835 +15,000 vol $2.19 each	130,000
Filed 2019-03-20 Tx date 2019-03-19	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$10,970 +5,000 vol $2.19 each	135,000
Filed 2019-03-17 Tx date 2019-03-14	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$18,993 +10,000 vol $1.90 each	143,014
Filed 2019-03-14 Tx date 2019-03-13	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$8,928 +5,000 vol $1.79 each	127,014
Filed 2019-03-14 Tx date 2019-03-13	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$17,394 +10,000 vol $1.74 each	122,014
Filed 2019-01-03 Tx date 2019-01-02	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	135,000
Filed 2019-01-03 Tx date 2019-01-02	$APS Aptose Biosciences Inc.	Ashe, Carol Gail 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	65,000
Filed 2019-01-03 Tx date 2019-01-02	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+400,000 vol	2,071,963
Filed 2019-01-03 Tx date 2019-01-02	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	160,334
Filed 2019-01-03 Tx date 2019-01-02	$APS Aptose Biosciences Inc.	Loewy, Caroline Marie 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	65,000
Filed 2019-01-03 Tx date 2019-01-02	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	152,500
Filed 2019-01-03 Tx date 2019-01-02	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	154,083
Filed 2019-01-03 Tx date 2019-01-02	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+300,000 vol	1,262,501
Filed 2018-10-17 Tx date 2018-10-15	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-50,000 vol	0
Filed 2018-10-17 Tx date 2018-10-15	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+50,000 vol	133,014
Filed 2018-10-17 Tx date 2018-10-15	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+50,000 vol	112,014
Filed 2018-10-17 Tx date 2018-10-15	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-50,000 vol	0
Filed 2018-10-09 Tx date 2018-10-08	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$21,250 +10,000 vol $2.13 each	83,014
Filed 2018-08-16 Tx date 2018-08-15	$APS Aptose Biosciences Inc.	Ashe, Carol Gail 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report		25,000
Filed 2018-07-16 Tx date 2018-07-16	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$31,100 +10,000 vol $3.11 each	73,014
Filed 2018-07-16 Tx date 2018-07-16	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$18,441 +6,000 vol $3.07 each	62,014
Filed 2018-07-16 Tx date 2018-07-13	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+50,000 vol	50,000
Filed 2018-07-16 Tx date 2018-07-13	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+50,000 vol	50,000
Filed 2018-04-30 Tx date 2018-04-25	$APS Aptose Biosciences Inc.	Loewy, Caroline Marie 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	25,000
Filed 2018-04-30 Tx date 2018-04-25	$APS Aptose Biosciences Inc.	Loewy, Caroline Marie 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2018-02-27 Tx date 2018-02-26	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,750 -500 vol $3.50 each	0
Filed 2018-01-23 Tx date 2018-01-19	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+60,000 vol	112,500
Filed 2018-01-23 Tx date 2018-01-22	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+400,000 vol	1,671,963
Filed 2018-01-23 Tx date 2018-01-19	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+300,000 vol	1,271,963
Filed 2018-01-23 Tx date 2018-01-22	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+350,000 vol	962,501
Filed 2018-01-23 Tx date 2018-01-19	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+150,000 vol	612,501
Filed 2018-01-23 Tx date 2018-01-19	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+60,000 vol	120,334
Filed 2018-01-23 Tx date 2018-01-19	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+60,000 vol	114,083
Filed 2018-01-23 Tx date 2018-01-19	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+60,000 vol	110,750
Filed 2018-01-23 Tx date 2018-01-19	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+60,000 vol	95,000
Filed 2017-08-16 Tx date 2017-08-15	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$9,750 +5,000 vol $1.95 each	50,000
Filed 2017-08-16 Tx date 2017-08-15	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$930.00 +500 vol $1.86 each	500
Filed 2017-08-16 Tx date 2017-08-15	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$60,000 +40,000 vol $1.50 each	115,000
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-5,000 vol	0
Filed 2017-06-30 Tx date 2017-06-29	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$16,400 +10,000 vol $1.64 each	45,000
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+5,000 vol	35,000
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$16,000 +10,000 vol $1.60 each	30,000
Filed 2017-06-30 Tx date 2017-06-27	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$25,670 +17,000 vol $1.51 each	20,000
Filed 2017-06-30 Tx date 2017-06-27	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$25,519 +16,900 vol $1.51 each
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-5,000 vol	0
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+5,000 vol	6,500
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-5,000 vol	0
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-7,900 -5,000 vol $1.58 each	0
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+5,000 vol	5,000
Filed 2017-06-30 Tx date 2013-06-27	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-50,000 vol	0
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-22,783.20 -18,986 vol $1.20 each	63,014
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+50,000 vol	82,000
Filed 2017-06-30 Tx date 2017-06-26	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$22,799 +20,000 vol $1.14 each	32,000
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-5,000 vol	0
Filed 2017-06-30 Tx date 2017-06-29	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,400 +5,000 vol $1.28 each	75,000
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+5,000 vol	70,000
Filed 2017-06-30 Tx date 2017-06-27	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$33,600 +30,000 vol $1.12 each	65,000
Filed 2017-06-30 Tx date 2017-06-26	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$29,415 +26,500 vol $1.11 each	35,000
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-50,000 vol	0
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-22,783.20 -18,986 vol $1.20 each	56,014
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+50,000 vol	75,000
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+5,000 vol
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Restricted Share Units 57 - Exercise of rights	-5,000 vol	0
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-2,694 -2,245 vol $1.20 each	16,254
Filed 2017-06-30 Tx date 2017-06-28	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+5,000 vol	18,499
Filed 2017-06-30 Tx date 2017-06-26	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$11,299 +10,000 vol $1.13 each	25,000
Filed 2017-06-09 Tx date 2017-06-06	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$6,899 +5,000 vol $1.38 each	52,500
Filed 2017-06-09 Tx date 2017-06-06	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$6,899 +5,000 vol $1.38 each	54,083
Filed 2017-06-09 Tx date 2017-06-06	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$6,899 +5,000 vol $1.38 each	50,750
Filed 2017-06-09 Tx date 2017-06-06	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$51,500 +50,000 vol $1.03 each	971,963
Filed 2017-06-09 Tx date 2017-06-06	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$5,150 +5,000 vol $1.03 each	35,000
Filed 2017-06-09 Tx date 2017-06-06	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$51,500 +50,000 vol $1.03 each	462,501
Filed 2017-06-09 Tx date 2017-06-06	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$5,150 +5,000 vol $1.03 each	60,334
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+5,000 vol	5,000
Filed 2017-03-31 Tx date 2011-04-07	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+10,000 vol	47,500
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+5,000 vol	5,000
Filed 2017-03-31 Tx date 2007-09-19	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+10,000 vol	49,083
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+5,000 vol	5,000
Filed 2017-03-31 Tx date 2013-06-27	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+10,000 vol	45,750
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+50,000 vol	50,000
Filed 2017-03-31 Tx date 2013-10-28	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	921,963
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+5,000 vol	5,000
Filed 2017-03-31 Tx date 2014-12-15	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+10,000 vol	30,000
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+50,000 vol	50,000
Filed 2017-03-31 Tx date 2013-11-29	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	412,501
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Restricted Share Units 56 - Grant of rights	+5,000 vol	5,000
Filed 2017-03-31 Tx date 2007-09-19	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Restricted Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-31 Tx date 2017-03-28	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+10,000 vol	55,334
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Williams, Elizabeth 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$76,400 +20,000 vol $3.82 each	76,416
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$38,200 +10,000 vol $3.82 each	37,500
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$38,200 +10,000 vol $3.82 each	39,083
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$229,200 +60,000 vol $3.82 each	312,501
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Thompson, Bradley 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$38,200 +10,000 vol $3.82 each	35,750
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$229,200 +60,000 vol $3.82 each	821,963
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$38,200 +10,000 vol $3.82 each	20,000
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$229,200 +60,000 vol $3.82 each	312,501
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$38,200 +10,000 vol $3.82 each	45,334
Filed 2016-04-04 Tx date 2016-03-31	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$38,200 +10,000 vol $3.82 each
Filed 2015-12-16 Tx date 2015-12-15	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$9,802 +2,900 vol $3.38 each	3,000
Filed 2015-12-16 Tx date 2015-12-15	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$333.00 +100 vol $3.33 each	100
Filed 2015-12-16 Tx date 2011-04-07	$APS Aptose Biosciences Inc.	Whitehead, Warren 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2015-12-02 Tx date 2015-11-30	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$12,000 +4,000 vol $3.00 each	12,000
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$310.00 +100 vol $3.10 each	8,000
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$12,480 +3,900 vol $3.20 each	7,900
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$12,480 +3,900 vol $3.20 each
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,875 +1,500 vol $3.25 each	8,500
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$16,200 +5,000 vol $3.24 each	7,000
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$16,200 +5,000 vol $3.24 each
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$321.00 +100 vol $3.21 each	2,000
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$321.00 +100 vol $3.21 each
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,584 +800 vol $3.23 each	1,900
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,584 +800 vol $3.23 each
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$321.00 +100 vol $3.21 each	1,100
Filed 2015-11-27 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,200 +1,000 vol $3.20 each	1,000
Filed 2015-11-27 Tx date 2014-12-15	$APS Aptose Biosciences Inc.	Platzer, Erich 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2015-11-24 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$3,150 +1,000 vol $3.15 each	1,500
Filed 2015-11-24 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,880 +2,000 vol $3.44 each	15,000
Filed 2015-11-24 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,500 +2,000 vol $3.25 each	13,000
Filed 2015-11-24 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,219 +400 vol $3.05 each	11,000
Filed 2015-11-24 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,873 +1,600 vol $3.05 each	10,600
Filed 2015-11-24 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,985 +1,000 vol $2.98 each	9,000
Filed 2015-11-24 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,988 +2,000 vol $2.99 each	8,000
Filed 2015-11-24 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,992 +1,000 vol $2.99 each	6,000
Filed 2015-11-24 Tx date 2015-11-24	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$15,000 +5,000 vol $3.00 each	13,499
Filed 2015-11-24 Tx date 2014-10-01	$APS Aptose Biosciences Inc.	Burger, Denis 4 - Director of Issuer Direct Ownership	Common Shares 37 - Stock split or consolidation	-93,488 vol	8,499
Filed 2015-09-09 Tx date 2014-07-18	$APS Lorus Therapeutics Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$338,800 +770,000 vol $0.44 each	2,310,000
Filed 2015-09-09 Tx date 2014-07-18	$APS Lorus Therapeutics Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$338,800 +770,000 vol $0.44 each
Filed 2015-09-09 Tx date 2014-07-18	$APS Lorus Therapeutics Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$334,950 +770,000 vol $0.435 each
Filed 2015-09-09 Tx date 2014-07-18	$APS Lorus Therapeutics Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$338,800 +770,000 vol $0.44 each	2,310,000
Filed 2015-09-09 Tx date 2014-07-18	$APS Lorus Therapeutics Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$334,950 +770,000 vol $0.435 each
Filed 2015-06-22 Tx date 2015-06-19	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-1,500 -500 vol $3.00 each	0
Filed 2015-06-22 Tx date 2014-10-10	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Warrants 37 - Stock split or consolidation	-5,500 vol	500
Filed 2015-06-22 Tx date 2015-06-19	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	$1,500 +500 vol $3.00 each	500
Filed 2015-06-22 Tx date 2007-09-19	$APS Aptose Biosciences Inc.	Vincent, Mark 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2015-06-11 Tx date 2015-06-10	$APS Aptose Biosciences Inc.	Williams, Elizabeth 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$139,200 +20,000 vol $6.96 each	56,416
Filed 2015-06-11 Tx date 2015-06-10	$APS Aptose Biosciences Inc.	Williams, Elizabeth 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report		36,416
Filed 2015-06-11 Tx date 2015-06-10	$APS Aptose Biosciences Inc.	Williams, Elizabeth 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		36
Filed 2015-06-11 Tx date 2015-06-10	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$417,600 +60,000 vol $6.96 each	252,501
Filed 2015-06-11 Tx date 2015-06-10	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$835,200 +120,000 vol $6.96 each	761,963
Filed 2015-06-11 Tx date 2015-06-10	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$417,600 +60,000 vol $6.96 each	252,501
Filed 2015-05-27 Tx date 2015-05-26	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,740 +300 vol $5.80 each	4,200
Filed 2015-05-27 Tx date 2015-05-26	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,892 +500 vol $5.78 each	3,900
Filed 2015-05-27 Tx date 2015-05-26	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,720 +800 vol $5.90 each	3,400
Filed 2015-05-27 Tx date 2015-05-26	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,951 +500 vol $5.90 each	5,000
Filed 2015-05-27 Tx date 2015-05-26	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,332 +400 vol $5.83 each	4,500
Filed 2015-05-27 Tx date 2015-05-26	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$591.99 +100 vol $5.92 each	4,100
Filed 2015-05-13 Tx date 2015-05-12	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,925 +500 vol $5.85 each	1,900
Filed 2015-05-13 Tx date 2015-05-12	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,720 +800 vol $5.90 each	1,400
Filed 2015-05-13 Tx date 2015-05-12	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,130 +700 vol $5.90 each	2,600
Filed 2015-05-12 Tx date 2014-10-01	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-2,117,499 vol	192,501
Filed 2015-05-12 Tx date 2015-05-11	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,812 +300 vol $6.04 each	600
Filed 2015-05-12 Tx date 2015-05-11	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,782 +300 vol $5.94 each	300
Filed 2015-05-12 Tx date 2013-11-29	$APS Aptose Biosciences Inc.	Vellanki, Avanish 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2015-05-12 Tx date 2014-10-01	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-7,061,587 vol	641,963
Filed 2015-05-12 Tx date 2015-05-11	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,534 +1,100 vol $5.94 each	4,000
Filed 2015-05-12 Tx date 2015-05-11	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,391 +900 vol $5.99 each	2,900
Filed 2015-05-12 Tx date 2015-05-08	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,040 +1,000 vol $6.04 each	2,000
Filed 2015-05-12 Tx date 2015-05-08	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,090 +1,000 vol $6.09 each	1,000
Filed 2015-05-12 Tx date 2015-05-08	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$60,900 +10,000 vol $6.09 each
Filed 2015-05-12 Tx date 2015-05-08	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$60,900 +10,000 vol $6.09 each
Filed 2015-05-12 Tx date 2013-10-28	$APS Aptose Biosciences Inc.	Rice, William Glenn 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2015-05-12 Tx date 2014-10-01	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Options 37 - Stock split or consolidation	-2,117,499 vol	192,501
Filed 2015-05-12 Tx date 2015-05-11	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,995 +500 vol $5.99 each	4,000
Filed 2015-05-12 Tx date 2015-05-11	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$495.09 +83 vol $5.96 each	3,500
Filed 2015-05-12 Tx date 2015-05-11	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,474 +917 vol $5.97 each	3,417
Filed 2015-05-12 Tx date 2015-05-11	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$111.72 +19 vol $5.88 each	2,500
Filed 2015-05-12 Tx date 2015-05-11	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,833 +481 vol $5.89 each	2,481
Filed 2015-05-12 Tx date 2015-05-08	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,549 +260 vol $5.96 each	2,000
Filed 2015-05-12 Tx date 2015-05-08	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,425 +740 vol $5.98 each	1,740
Filed 2015-05-12 Tx date 2015-05-08	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$1,195 +200 vol $5.97 each	1,000
Filed 2015-05-12 Tx date 2015-05-08	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,800 +800 vol $6.00 each	800
Filed 2015-05-08 Tx date 2013-11-29	$APS Aptose Biosciences Inc.	Chow, Gregory Kwok Lee 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report